|
General characteristics (n = 219)
|
Total (n = 219)
|
No IR (n = 144)
|
IR (n = 75)
|
PR
|
P
|
|---|
|
Male, n (%)
|
147 (67.1)
|
96 (66.7)
|
51 (68.0)
|
1.041
|
0.844
|
|
Age
| | | | |
0.007
|
|
≤ 35 years, n (%)
|
95 (43.4)
|
70 (48.6)
|
25 (33.3)
|
1.000
|
Reference
|
|
36-45 years, n (%)
|
74 (33.8)
|
50 (34.7)
|
24 (32.0)
|
1.232
|
0.398
|
|
≥ 46 years, n (%)
|
50 (22.8)
|
24 (16.7)
|
26 (34.7)
|
1.976
|
0.002
|
|
Hispanics, n (%)
|
190 (86.7)
|
124 (86.1)
|
66 (88.0)
|
1.119
|
0.709
|
|
Family history of T2DM, n (%)
|
51 (23.3)
|
34 (23.6)
|
17 (22.7)
|
0.965
|
0.877
|
|
Cigarrette smoker, n (%)
|
54 (24.7)
|
40 (27.8)
|
14 (18.7)
|
0.701
|
0.186
|
|
>1 year on HAART, n (%)
|
167 (76.3)
|
106 (73.6)
|
61 (81.3)
|
1.357
|
0.249
|
|
HAART regimen with PI, n (%)
|
20 (9.1)
|
11 (7.6)
|
9 (12.0)
|
1.357
|
0.235
|
- Abbreviations: HAART highly active antiretroviral therapy; IR insulin resistance; PR prevalence ratio; PI protease inhibitor; T2DM type 2 diabetes mellitus
